YCChem Co Ltd
YCChem Co Ltd is a specialty chemicals company that produces and sells chemical products, primarily serving industrial and manufacturing sectors.
Business. YCChem Co Ltd is a specialty chemicals company listed on the KOSDAQ under the ticker symbol 112290.KQ. The firm operates within the Basic Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the specialty chemicals market.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
YCChem Co Ltd is a specialty chemicals company listed on the KOSDAQ under the ticker symbol 112290.KQ. The firm operates within the Basic Materials sector, focusing on the production and sale of chemical products. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the specialty chemicals market.
YCChem's capital structure is highly leveraged, with a debt-to-equity ratio of 1.7, indicating significant reliance on long-term debt to fund operations. The company's liquidity position is constrained, as evidenced by a current ratio of 0.8 and negative net cash after subtracting total debt. Free cash flow is negative at -4.4 billion KRW, driven by capital expenditures of -14.1 billion KRW, which outpace operating cash flow of 1.6 billion KRW.
Profitability metrics show mixed performance. Return on equity (ROE) is 9.4%, outperforming the industry median of 6.2%, but return on assets (ROA) of 2.7% lags behind the median of 4.1%. The company reported a net income of 4.6 billion KRW despite an operating loss of 1.8 billion KRW, suggesting non-operating income or asset revaluation contributed to profitability.
Geographic and segment exposure is not disclosed in the available data, but the company's revenue concentration in a single business line (specialty chemicals) introduces operational risk. The absence of segment reporting limits visibility into diversification or growth drivers.
Growth trajectory is uncertain. Revenue for the latest period was 83.1 billion KRW, but operating income turned negative for the first time in recent history. Analysts have issued a mean recommendation of 2.0 (hold), with no strong buy ratings and only one buy rating. Price targets are uniformly set at 16,500 KRW, indicating limited upside potential.
Risk factors include liquidity constraints and high leverage. The company's free cash flow deficit and capital expenditure intensity suggest pressure on working capital. Dilution risk is currently low, as shares outstanding have not changed between basic and diluted counts, but the absence of a liquidity buffer increases vulnerability to market shocks.
Recent filings and transcripts are not available in the input data, but the operating loss and negative free cash flow suggest potential operational or strategic challenges. The company may need to restructure debt or secure additional financing to maintain operations.
- YCChem is highly leveraged with a debt-to-equity ratio of 1.7 and negative net cash after debt.
- ROE of 9.4% outperforms the industry median, but ROA of 2.7% underperforms.
- Free cash flow is negative at -4.4 billion KRW, driven by capital expenditures of -14.1 billion KRW.
- Analysts have issued a mean recommendation of 2.0 (hold) with no strong buy ratings.
- The company's operating loss and liquidity constraints raise concerns about financial stability.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 832,00 |
| Revenue | —no estimate | —no estimate | 117,1B KRW |
| Operating income | —no estimate | —no estimate | 16,7B KRW |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- YCChem Co Ltd Market data — financials · 2026-05-26
- YCChem Co Ltd Market data — analyst estimates · 2026-05-26